Mapping the interaction sites of human and avian influenza A viruses and complement factor H

The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the comp...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1352022
Main Authors Rabeeah, Iman, Billington, Elizabeth, Nal, Béatrice, Sadeyen, Jean-Remy, Pathan, Ansar A, Iqbal, Munir, Temperton, Nigel J, Zipfel, Peter F, Skerka, Christine, Kishore, Uday, Shelton, Holly
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the significance of which for the virus or host is yet to be elucidated.
AbstractList The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects “self” cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the in vivo significance of which for the virus or host is yet to be elucidated.
The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the significance of which for the virus or host is yet to be elucidated.
The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the in vivo significance of which for the virus or host is yet to be elucidated.
Author Iqbal, Munir
Zipfel, Peter F
Pathan, Ansar A
Sadeyen, Jean-Remy
Kishore, Uday
Temperton, Nigel J
Skerka, Christine
Billington, Elizabeth
Shelton, Holly
Nal, Béatrice
Rabeeah, Iman
AuthorAffiliation 7 Department of Veterinary Medicine, United Arab Emirates University , Al Ain , United Arab Emirates
1 Pirbright Institute , Woking , United Kingdom
5 Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology , Jena , Germany
6 Institute of Microbiology, Friedrich Schiller University , Jena , Germany
8 Zayed Centre for Biomedical Sciences, U.A.E. University , Al Ain , United Arab Emirates
4 Viral Pseudotype Unit, University of Kent , Chatham , United Kingdom
3 Aix-Marseille Université, CNRS, INSERM, CIML , Marseille , France
2 Biosciences, College of Health, Medicine and Life Sciences, Brunel University London , Uxbridge , United Kingdom
AuthorAffiliation_xml – name: 1 Pirbright Institute , Woking , United Kingdom
– name: 6 Institute of Microbiology, Friedrich Schiller University , Jena , Germany
– name: 2 Biosciences, College of Health, Medicine and Life Sciences, Brunel University London , Uxbridge , United Kingdom
– name: 7 Department of Veterinary Medicine, United Arab Emirates University , Al Ain , United Arab Emirates
– name: 8 Zayed Centre for Biomedical Sciences, U.A.E. University , Al Ain , United Arab Emirates
– name: 4 Viral Pseudotype Unit, University of Kent , Chatham , United Kingdom
– name: 3 Aix-Marseille Université, CNRS, INSERM, CIML , Marseille , France
– name: 5 Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology , Jena , Germany
Author_xml – sequence: 1
  givenname: Iman
  surname: Rabeeah
  fullname: Rabeeah, Iman
  organization: Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom
– sequence: 2
  givenname: Elizabeth
  surname: Billington
  fullname: Billington, Elizabeth
  organization: Pirbright Institute, Woking, United Kingdom
– sequence: 3
  givenname: Béatrice
  surname: Nal
  fullname: Nal, Béatrice
  organization: Aix-Marseille Université, CNRS, INSERM, CIML, Marseille, France
– sequence: 4
  givenname: Jean-Remy
  surname: Sadeyen
  fullname: Sadeyen, Jean-Remy
  organization: Pirbright Institute, Woking, United Kingdom
– sequence: 5
  givenname: Ansar A
  surname: Pathan
  fullname: Pathan, Ansar A
  organization: Biosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom
– sequence: 6
  givenname: Munir
  surname: Iqbal
  fullname: Iqbal, Munir
  organization: Pirbright Institute, Woking, United Kingdom
– sequence: 7
  givenname: Nigel J
  surname: Temperton
  fullname: Temperton, Nigel J
  organization: Viral Pseudotype Unit, University of Kent, Chatham, United Kingdom
– sequence: 8
  givenname: Peter F
  surname: Zipfel
  fullname: Zipfel, Peter F
  organization: Institute of Microbiology, Friedrich Schiller University, Jena, Germany
– sequence: 9
  givenname: Christine
  surname: Skerka
  fullname: Skerka, Christine
  organization: Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
– sequence: 10
  givenname: Uday
  surname: Kishore
  fullname: Kishore, Uday
  organization: Zayed Centre for Biomedical Sciences, U.A.E. University, Al Ain, United Arab Emirates
– sequence: 11
  givenname: Holly
  surname: Shelton
  fullname: Shelton, Holly
  organization: Pirbright Institute, Woking, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38698856$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1v1DAQhi1URD_oH-CAfOSyi79jn1BVQVupiAvckCzHGe-6SuxgJyuVX0-2u1TtXGbkeecZj95zdJJyAoQ-ULLmXJvPIQ7DvGaEiTXlcsnsDTqjSokVZ0ycvKhP0WWtD2QJYTjn8h065VoZraU6Q7-_u3GMaYOnLeCYJijOTzEnXOMEFeeAt_PgEnapw24Xlyqm0M-Q_jp8hXexzHWR7bs-D2MPA6QJh4WRC759j94G11e4POYL9Ovb15_Xt6v7Hzd311f3Ky8YmVZSOhMUDUFA450SimoDnTSypQBMGtV0hDVMd4S4TqrWMMZ9y73hOjQtF_wC3R24XXYPdixxcOXRZhft00MuG-vKFH0PVmtNnQoeGuDCBd4GqrXrmqCp6IjUC-vLgTXO7QCdX-4prn8Ffd1JcWs3eWcpJUoQxRbCpyOh5D8z1MkOsXroe5cgz9VyIonhSjRqkbKD1Jdca4HwvIcSu7fZPtls9zbbo83L0MeXP3we-W8q_weKBab3
Cites_doi 10.1038/ng912
10.1186/s12974-019-1675-1
10.4049/jimmunol.130.3.1317
10.3389/fimmu.2017.00571
10.1002/eji.1830261017.
10.1128/JVI.01990-07
10.1159/000335670
10.1128/jvi.70.7.4253-4260.1996
10.1016/S0021-9258(18)83370-1
10.1111/imr.12475
10.1128/IAI.01923-06
10.3201/eid2208.160146
10.3389/fimmu.2020.00355
10.1371/journal.pone.0025755
10.3389/fimmu.2015.00262
10.1038/nm0402-373
10.1073/pnas.0605668103
10.3390/vaccines9070741
10.1099/0022-1317-72-4-915
10.1128/JVI.06577-11
10.1074/jbc.M109.063495
10.1093/oxfordjournals.aje.a118408
10.1099/jgv.0.000584
10.1007/BF01120205
10.4049/jimmunol.155.12.5663
10.1371/journal.ppat.1000085
10.1016/S0042-6822(03)00068-0
10.1007/978-1-62703-724-2_17
10.3389/fmicb.2017.01117
10.1084/jem.182.2.501
10.1371/journal.pone.0082094
10.1016/j.molimm.2010.05.007
10.1074/jbc.M002903200
10.1074/jbc.271.23.13417
10.1111/j.1750-2659.2007.00016.x
10.1128/JVI.00174-13
10.3389/fimmu.2015.00257
10.3390/ijerph14030263
10.1099/0022-1317-75-3-615
10.1016/S0140-6736(17)33293-2
10.1099/vir.0.014316-0
10.3389/fimmu.2021.602277
10.1183/09031936.98.11040958
10.1128/JVI.02128-06
10.4049/jimmunol.121.4.1437
10.1016/j.molimm.2006.12.001
10.21037/jtd
10.1016/j.vaccine.2008.11.015
ContentType Journal Article
Copyright Copyright © 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton.
Copyright © 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton
Copyright_xml – notice: Copyright © 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton.
– notice: Copyright © 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2024.1352022
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
EndPage 1352022
ExternalDocumentID oai_doaj_org_article_8881a6fce7e34af3bf188ad7f814d058
10_3389_fimmu_2024_1352022
38698856
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
ITC
5PM
ID FETCH-LOGICAL-c420t-55a9f61ff4e7ca646189ed595b1ee25967d02728d00ad56b9223cb3c938f7b343
IEDL.DBID RPM
ISSN 1664-3224
IngestDate Fri Oct 04 13:05:55 EDT 2024
Tue Sep 17 21:27:59 EDT 2024
Sat Aug 17 05:01:20 EDT 2024
Thu Sep 26 18:51:18 EDT 2024
Wed Oct 09 10:26:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords entry inhibitor
human influenza
avian influenza
complement
factor H
pseudotype
influenza A virus
Language English
License Copyright © 2024 Rabeeah, Billington, Nal, Sadeyen, Pathan, Iqbal, Temperton, Zipfel, Skerka, Kishore and Shelton.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-55a9f61ff4e7ca646189ed595b1ee25967d02728d00ad56b9223cb3c938f7b343
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Annapurna Nayak, Kedrion Biopharma Inc, United Kingdom
Edited by: Alok Agrawal, East Tennessee State University, United States
Maciej Cedzynski, Polish Academy of Sciences, Poland
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11064062/
PMID 38698856
PQID 3050936476
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_8881a6fce7e34af3bf188ad7f814d058
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11064062
proquest_miscellaneous_3050936476
crossref_primary_10_3389_fimmu_2024_1352022
pubmed_primary_38698856
PublicationCentury 2000
PublicationDate 2024-04-18
PublicationDateYYYYMMDD 2024-04-18
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-18
  day: 18
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Jozsi (B42) 2007; 44
Ha (B43) 2003; 309
Kim (B19) 2013; 87
Hui (B3) 2017; 9
Ferreira (B22) 2010; 47
Mawatari (B17) 2013; 8
Józsi (B24) 2017; 8
Kühn (B38) 1995; 155
Friedman (B16) 1996; 70
Kühn (B37) 1996; 26
Woodman (B47) 2007; 75
Hidaka (B15) 1991; 72
Beebe (B7) 1983; 130
Murugaiah (B28) 2020; 11
Reed (B31) 1938; 27
Zaiss (B27) 2008; 82
James (B30) 2016; 97
Sim (B35) 1983; 3
Iuliano (B1) 2018; 391
Anders (B11) 1994; 75
Pan (B12) 2012; 4
Merle (B6) 2015; 6
Jayasekera (B8) 2007; 81
Zipfel (B25) 2008; 26
Mazumdar (B18) 2012; 86
Moore (B36) 2021; 12
Wu (B2) 2017; 14
Hicks (B9) 1978; 121
Zhang (B21) 2009; 90
van Doremalen (B29) 2011; 6
Pickering (B46) 2002; 31
Jokiranta (B41) 2000; 275
Durrer (B45) 1996; 271
Temperton (B33) 2007; 1
Kasanmoentalib (B48) 2019; 16
Shen (B4) 2016; 22
Chung (B26) 2006; 103
Persson (B40) 1998; 11
Harter (B44) 1989; 264
Yu (B34) 2014
Merle (B5) 2015; 6
Saifuddin (B14) 1995; 182
Sakaue (B39) 2010; 285
Del Rosario (B32) 2021; 9
Agrawal (B13) 2017; 8
Kopf (B10) 2002; 8
Shaw (B20) 2008; 4
Schmidt (B23) 2016; 274
References_xml – volume: 31
  year: 2002
  ident: B46
  article-title: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H
  publication-title: Nat Genet
  doi: 10.1038/ng912
  contributor:
    fullname: Pickering
– volume: 16
  start-page: 279
  year: 2019
  ident: B48
  article-title: Complement factor H contributes to mortality in humans and mice with bacterial meningitis
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-019-1675-1
  contributor:
    fullname: Kasanmoentalib
– volume: 130
  year: 1983
  ident: B7
  article-title: Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement
  publication-title: J Immunol
  doi: 10.4049/jimmunol.130.3.1317
  contributor:
    fullname: Beebe
– volume: 8
  year: 2017
  ident: B24
  article-title: Factor H family proteins in complement evasion of microorganisms
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00571
  contributor:
    fullname: Józsi
– volume: 26
  year: 1996
  ident: B37
  article-title: Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830261017.
  contributor:
    fullname: Kühn
– volume: 82
  year: 2008
  ident: B27
  article-title: Complement is an essential component of the immune response to adeno-associated virus vectors
  publication-title: J Virol
  doi: 10.1128/JVI.01990-07
  contributor:
    fullname: Zaiss
– volume: 4
  year: 2012
  ident: B12
  article-title: L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo
  publication-title: J Innate Immun
  doi: 10.1159/000335670
  contributor:
    fullname: Pan
– volume: 70
  year: 1996
  ident: B16
  article-title: Immune evasion properties of herpes simplex virus type 1 glycoprotein gC
  publication-title: J Virol
  doi: 10.1128/jvi.70.7.4253-4260.1996
  contributor:
    fullname: Friedman
– volume: 264
  year: 1989
  ident: B44
  article-title: Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the fusion peptide
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)83370-1
  contributor:
    fullname: Harter
– volume: 274
  year: 2016
  ident: B23
  article-title: Protection of host cells by complement regulators
  publication-title: Immunol Rev
  doi: 10.1111/imr.12475
  contributor:
    fullname: Schmidt
– volume: 75
  year: 2007
  ident: B47
  article-title: Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection
  publication-title: Infect Immun
  doi: 10.1128/IAI.01923-06
  contributor:
    fullname: Woodman
– volume: 22
  year: 2016
  ident: B4
  article-title: Novel reassortant avian influenza A(H5N6) viruses in humans, guangdong, China, 2015
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2208.160146
  contributor:
    fullname: Shen
– volume: 11
  year: 2020
  ident: B28
  article-title: Complement-independent modulation of influenza A virus infection by factor H
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00355
  contributor:
    fullname: Murugaiah
– volume: 6
  year: 2011
  ident: B29
  article-title: A single amino acid in the HA of pH1N1 2009 influenza virus affects cell tropism in human airway epithelium, but not transmission in ferrets
  publication-title: PloS One
  doi: 10.1371/journal.pone.0025755
  contributor:
    fullname: van Doremalen
– volume: 6
  year: 2015
  ident: B5
  article-title: Complement system part I - molecular mechanisms of activation and regulation
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00262
  contributor:
    fullname: Merle
– volume: 8
  year: 2002
  ident: B10
  article-title: Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
  publication-title: Nat Med
  doi: 10.1038/nm0402-373
  contributor:
    fullname: Kopf
– volume: 103
  year: 2006
  ident: B26
  article-title: West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0605668103
  contributor:
    fullname: Chung
– volume: 9
  start-page: 741
  year: 2021
  ident: B32
  article-title: Temperton, exploiting pan influenza A and pan influenza B pseudotype libraries for efficient vaccine antigen selection
  publication-title: Vaccines
  doi: 10.3390/vaccines9070741
  contributor:
    fullname: Del Rosario
– volume: 72
  year: 1991
  ident: B15
  article-title: Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-72-4-915
  contributor:
    fullname: Hidaka
– volume: 86
  year: 2012
  ident: B18
  article-title: Hepatitis C virus proteins inhibit C3 complement production
  publication-title: J Virol
  doi: 10.1128/JVI.06577-11
  contributor:
    fullname: Mazumdar
– volume: 285
  year: 2010
  ident: B39
  article-title: Factor H in porcine seminal plasma protects sperm against complement attack in genital tracts
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.063495
  contributor:
    fullname: Sakaue
– volume: 27
  year: 1938
  ident: B31
  article-title: A simple method of estimating 50% end points
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a118408
  contributor:
    fullname: Reed
– volume: 97
  year: 2016
  ident: B30
  article-title: Influenza A virus PB1-F2 protein prolongs viral shedding in chickens lengthening the transmission window
  publication-title: J Gen Virol
  doi: 10.1099/jgv.0.000584
  contributor:
    fullname: James
– volume: 3
  year: 1983
  ident: B35
  article-title: Monoclonal antibodies against the complement control protein factor H (beta 1 H)
  publication-title: Biosci Rep
  doi: 10.1007/BF01120205
  contributor:
    fullname: Sim
– volume: 155
  year: 1995
  ident: B38
  article-title: Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.12.5663
  contributor:
    fullname: Kühn
– volume: 4
  year: 2008
  ident: B20
  article-title: Cellular proteins in influenza virus particles
  publication-title: PloS Pathog
  doi: 10.1371/journal.ppat.1000085
  contributor:
    fullname: Shaw
– volume: 309
  year: 2003
  ident: B43
  article-title: X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus
  publication-title: Virology
  doi: 10.1016/S0042-6822(03)00068-0
  contributor:
    fullname: Ha
– volume-title: The Complement System: Methods and Protocols
  year: 2014
  ident: B34
  article-title: Purification, quantification, and functional analysis of complement factor H
  doi: 10.1007/978-1-62703-724-2_17
  contributor:
    fullname: Yu
– volume: 8
  start-page: 1117
  year: 2017
  ident: B13
  article-title: Complement evasion strategies of viruses: an overview
  publication-title: Front Microbiol.
  doi: 10.3389/fmicb.2017.01117
  contributor:
    fullname: Agrawal
– volume: 182
  year: 1995
  ident: B14
  article-title: Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1
  publication-title: J Exp Med
  doi: 10.1084/jem.182.2.501
  contributor:
    fullname: Saifuddin
– volume: 8
  year: 2013
  ident: B17
  article-title: Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4
  publication-title: PloS One
  doi: 10.1371/journal.pone.0082094
  contributor:
    fullname: Mawatari
– volume: 47
  year: 2010
  ident: B22
  article-title: Complement control protein factor H: the good, the bad, and the inadequate
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2010.05.007
  contributor:
    fullname: Ferreira
– volume: 275
  year: 2000
  ident: B41
  article-title: Each of the three binding sites on complement factor H interacts with a distinct site on C3b
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M002903200
  contributor:
    fullname: Jokiranta
– volume: 271
  year: 1996
  ident: B45
  article-title: H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.23.13417
  contributor:
    fullname: Durrer
– volume: 1
  year: 2007
  ident: B33
  article-title: A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies
  publication-title: Influenza Other Respir Viruses
  doi: 10.1111/j.1750-2659.2007.00016.x
  contributor:
    fullname: Temperton
– volume: 87
  year: 2013
  ident: B19
  article-title: Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function
  publication-title: J Virol
  doi: 10.1128/JVI.00174-13
  contributor:
    fullname: Kim
– volume: 6
  year: 2015
  ident: B6
  article-title: Role in immunity
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2015.00257
  contributor:
    fullname: Merle
– volume: 14
  start-page: 263
  year: 2017
  ident: B2
  article-title: Comparative epidemiology of human fatal infections with novel, high (H5N6 and H5N1) and low (H7N9 and H9N2) pathogenicity avian influenza A viruses
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph14030263
  contributor:
    fullname: Wu
– volume: 75
  year: 1994
  ident: B11
  article-title: Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-75-3-615
  contributor:
    fullname: Anders
– volume: 391
  year: 2018
  ident: B1
  article-title: Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)33293-2
  contributor:
    fullname: Iuliano
– volume: 90
  year: 2009
  ident: B21
  article-title: Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.014316-0
  contributor:
    fullname: Zhang
– volume: 12
  year: 2021
  ident: B36
  article-title: Hijacking factor H for complement immune evasion
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.602277
  contributor:
    fullname: Moore
– volume: 11
  year: 1998
  ident: B40
  article-title: Plasma-derived proteins in airway defence, disease and repair of epithelial injury
  publication-title: Eur Respir J
  doi: 10.1183/09031936.98.11040958
  contributor:
    fullname: Persson
– volume: 81
  year: 2007
  ident: B8
  article-title: Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity
  publication-title: J Virol
  doi: 10.1128/JVI.02128-06
  contributor:
    fullname: Jayasekera
– volume: 121
  year: 1978
  ident: B9
  article-title: The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.121.4.1437
  contributor:
    fullname: Hicks
– volume: 44
  year: 2007
  ident: B42
  article-title: The C-terminus of complement factor H is essential for host cell protection
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2006.12.001
  contributor:
    fullname: Jozsi
– volume: 9
  year: 2017
  ident: B3
  article-title: Avian influenza A (H7N9) virus infections in humans across five epidemics in mainland China, 2013-2017
  publication-title: J Thorac Dis
  doi: 10.21037/jtd
  contributor:
    fullname: Hui
– volume: 26
  year: 2008
  ident: B25
  article-title: The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.11.015
  contributor:
    fullname: Zipfel
SSID ssj0000493335
Score 2.4193077
Snippet The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical,...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1352022
SubjectTerms Animals
avian influenza
Binding Sites
Birds - virology
complement
Complement Factor H - immunology
Complement Factor H - metabolism
factor H
Hemagglutinin Glycoproteins, Influenza Virus - immunology
Hemagglutinin Glycoproteins, Influenza Virus - metabolism
Host-Pathogen Interactions - immunology
human influenza
Humans
Immunology
influenza A virus
Influenza A virus - immunology
Influenza A virus - physiology
Influenza A Virus, H3N2 Subtype - immunology
Influenza A Virus, H9N2 Subtype - immunology
Influenza in Birds - immunology
Influenza in Birds - metabolism
Influenza in Birds - virology
Influenza, Human - immunology
Influenza, Human - metabolism
Influenza, Human - virology
Protein Binding
pseudotype
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1dSxwxFA0iCL5Ia9WurZKCbzI4mZtkMo8qylKwTxV8EEI-dQvOyn5B--t7k6yyK0Jf-jQwCUw4NzM5Z5J7LiEnEYQBw6EKuCBU3ILA7yDEylsWm8YEx1nKHb75IYe3_PuduFsp9ZXOhBV74ALcGSo0ZmR0oQ3ATQQbmVLGt1Ex7mtR0nyZWBFTvwrvBQBRsmRQhXVncfT0NEc92PBU6gGvzdpKlA3732OZbw9Lrqw-1x_IzpI20vMy3I9kI_S7ZKsUkvz9idzfmOSz8ECRztHkADEp-Qo07Q1P6TjSXIuPmt5Ts8AZgZ1ycZI_hp7TxWgyn2K31JqPmOdfhrSU4qHDPXJ7ffXzclgt6yZUjjf1rBLCdFGyGHlonZFcMtUFLzphWQgod2TrUYw2yte18ULaDimCs-A6ULG1wGGfbPbjPnwm1CCdq72XnRUtjw6scHUwsfFOuJbXYUBOXzDUz8UeQ6OsSIjrjLhOiOsl4gNykWB-7ZmsrfMNDLheBlz_K-AD8u0lSBpfhbS_Yfownk81JC-b5IcvB-SgBO31UaBkp5TAFrUWzrWxrLf0o8dst40ESSLtaQ7_x-i_kO2ESNqPYuor2ZxN5uEIac3MHucZ_Bfcf_ee
  priority: 102
  providerName: Directory of Open Access Journals
Title Mapping the interaction sites of human and avian influenza A viruses and complement factor H
URI https://www.ncbi.nlm.nih.gov/pubmed/38698856
https://www.proquest.com/docview/3050936476/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC11064062
https://doaj.org/article/8881a6fce7e34af3bf188ad7f814d058
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoNBLSdu03bYJKvQWnLU8kiwf05B0KWzIoYE9FISe6YauN-wjkP76juR1yJaeerHBkrGZGXvmk2a-IeRzBGHAcCgCOoSCWxD4H4RYeMtiVZngOEu1w-NLObrm3yZiskNkXwuTk_adnZ60v2Yn7fRnzq28m7lhnyc2vBqfocuS6Iiq4S7ZrQGeYPTbLuYFANFVyCACa4ZxOputEQtWPLV5wHO15YUyWf-_Isy_EyWfeJ6LffJiEzLS0-7VXpKd0L4iz7omkg-vyY-xSRwLNxRDOZrYHxZdrQJN-8JLOo809-GjpvXU3KM14KTcmOS3oaf0frpYL3FaGs3p5Xm5kHZteOjogFxfnH8_GxWbngmF41W5KoQwTZQsRh5qZySXTDXBi0ZYFgJCHVl7BKKV8mVpvJC2wfDAWXANqFhb4PCG7LXzNrwj1GAoV3ovGytqHh1Y4cpgYuWdcDUvw4Ac9zLUdx01hkZIkSSus8R1krjeSHxAviQxP85MtNb5wnxxozfK1QjHmZHRhToANxFsZEoZX0fFuC-FGpBPvZI0fgZpb8O0Yb5eakg8NokLXw7I205pj48CJRulBI6oLXVuvcv2CFpeptruLe39_9_6gTxPckg7UEx9JHurxTocYiCzskd5AQCPXyfsKNvwH0hP9_c
link.rule.ids 230,315,733,786,790,870,891,2115,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgQX3oXlaSRuKLtJ_IhzLBXVAt2KQyt6QLL8LAtsttrdVKK_nrGzqboVFzhFyjiK48_OzNgz3wC8DZRrqhnNPCqEjBnK8T9IQ-ZMEcpSe8uKmDs8ORTjY_bphJ9sgehzYVLQvjXTYfNrNmym31Ns5dnMjvo4sdGXyR6qLIGKqBzdgJu4YMvqipf-o7N6KaW8y5FBH6wehels1qI3WLJY6AGv5YYeSnT9f7Mxr4dKXtE9-_fga9_rLuTk57BdmaG9uEbo-O-fdR_urs1RstvJH8CWbx7Cra5A5e9H8G2iI3_DKUEzkURmiUWXB0HimfOSzANJNf6IbhzR5zjTsFEqenKhyS45ny7aJTaL0hS6nrYiSVfih4wfw_H-h6O9cbaux5BZVuarjHNdB1GEwHxltWCikLV3vOam8B7dKFE5dHJL6fJcOy5MjaaHNdTWVIbKUEZ3YLuZN_4pEI1mYu6cqA2vWLDUcJt7HUpnua1Y7gfwrkdHnXW0GwrdlYilSliqiKVaYzmA9xHAy5aRMjvdmC9O1XqEFbr6hRbB-spTpgM1oZBSuyrIgrmcywG86eFXuMTiuYlu_LxdKho5ciLPvhjAk246XL6KSlFLyVEiNybKRl82JQh_ovHu4X72_4--htvjo8mBOvh4-Pk53IljEk-6CvkCtleL1r9Eg2llXqXV8Qdmjxg9
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagCNSXcpctl5F4Q9kcPuI8lsJqObbqA5UqgWT5LNuy2dXuphL99YydpOpWPPUpUjxRHM84M2N__gah954wRRQliQOHkFBNGPwHiU-szn1RKGdoHs4OTw75-Jh-PWEnHapy1cEqa6Onw_rPbFhPf0ds5WJm0h4nlh5NDsBlcXBERbqwPr2L7sGkLaprmfpZG_kSQlh7TgbysCr109msgYywoKHYA1yLDV8UKfv_F2fehEte8z-jh-hn3_MWdnI-bNZ6aC5vkDre7tMeoZ0uLMX7rcxjdMfVT9D9tlDl36fo10QFHodTDOEiDgwTy_Y8BA57zys89zjW-sOqtlhdgMWBUCx-cqnwPr6YLpsViIXWCGGPS5K4LfWDx8_Q8ejzj4Nx0tVlSAwtsnXCmKo8z72nrjSKU56LyllWMZ07B-kULy0ku4WwWaYs47qCEMRoYioifKkJJc_RVj2v3QuEFYSLmbW80qyk3hDNTOaUL6xhpqSZG6APvYbkoqXfkJC2BH3KqE8Z9Ck7fQ7Qx6DEK8lAnR1vzJenshtlCSl_rrg3rnSEKk-0z4VQtvQipzZjYoDe9SYgYaqF_RNVu3mzkiRw5QS-fT5Au61JXL2KCF4JwaBFbBjLRl82W8AEIp13r_K92z_6Fj04-jSS378cfnuJtsOQhA2vXLxCW-tl415D3LTWb-IE-QcdIhq9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mapping+the+interaction+sites+of+human+and+avian+influenza+A+viruses+and+complement+factor+H&rft.jtitle=Frontiers+in+immunology&rft.au=Rabeeah%2C+Iman&rft.au=Billington%2C+Elizabeth&rft.au=Nal%2C+B%C3%A9atrice&rft.au=Sadeyen%2C+Jean-Remy&rft.date=2024-04-18&rft.eissn=1664-3224&rft.volume=15&rft.spage=1352022&rft_id=info:doi/10.3389%2Ffimmu.2024.1352022&rft_id=info%3Apmid%2F38698856&rft.externalDocID=38698856
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon